[1]
M. M. Dolzhenko and S. A. Bondarchuk, “Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension”, Zaporozhye Medical Journal, vol. 23, no. 6, pp. 791–799, Oct. 2021.